Institution statistics

DEUTSCHES KREBSFORSCHUNGSZENTRUM - Germany 

Ranking results:

2012
Criterium:Position:
Overall Score:500-600
Total Project Funding:> 1000
Total Project Funding:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Project Funding per Partner:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Number of Projects:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Partner Constancy:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Project Leadership Index:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Diversity Index:> 1000
Diversity Index:> 1000
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:300-400
Networking Rank (Reputation):400-500
Partner Constancy:700-800
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:400-500
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:300-400
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000

European project participation (2000-01-01 - 2013-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Total funding / No of participants

Projects:
Leadership:

Total number of projects: 102
As coordinator: 5
As participant: 82
Sole participant: 15
Coordinator / Participant Ratio: 0.06*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2000 0 2.625.000 238.636 1
2001 0 328.901 32.890 1
2003 0 2.200.303 275.038 2
2004 2.574.811 97.165.051 8.087.993 2 14
2005 8.644.181 70.077.480 7.756.418 5 13
2006 0 88.414.466 4.416.755 12
2007 1.444.695 5.914.351 1.900.654 1 2
2008 0 65.311.985 3.925.581 9
2009 2.811.756 43.272.253 5.460.854 3 7
2010 3.875.279 40.930.966 6.767.542 2 4
2011 8.098.428 25.638.979 2.514.445 3 5
2012 4.851.313 38.621.319 8.207.025 4 6
2013 0 29.881.892 4.179.002 6
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE24
KAROLINSKA INSTITUTE19
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE15
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE14
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD13
UNIVERSITY COLLEGE LONDON11
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER10
MEDICAL RESEARCH COUNCIL10
EUROPEAN MOLECULAR BIOLOGY LABORATORY9
LUNDS UNIVERSITET9
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE9
UNIVERSITY OF COPENHAGEN8
LEIDEN UNIVERSITY MEDICAL CENTER7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS6
DANISH CANCER SOCIETY6
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III6
INSTITUT PASTEUR6
KING'S COLLEGE LONDON6
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV6
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS6
UNIVERSITY OF HELSINKI6
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR5
GENETHON5
INSTITUT CURIE5
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI5
LUDWIG INSTITUT FUER KREBSFORSCHUNG5
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
MEDIZINISCHE UNIVERSITAET INNSBRUCK5
UNIVERSITAT AUTONOMA DE BARCELONA5
UNIVERSITEIT UTRECHT5
UNIVERSITY COLLEGE DUBLIN5
UNIVERSITY OF AARHUS5
UNIVERSITY OF BIRMINGHAM5
UNIVERSITY OF LEEDS5
VRIJE UNIVERSITEIT BRUSSEL5
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS4
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG4
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE4
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
GATC BIOTECH4
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT4
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE4
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE4
ISTITUTO EUROPEO DI ONCOLOGIA4
KATHOLIEKE UNIVERSITEIT LEUVEN4
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN4
MEDIZINISCHE HOCHSCHULE HANNOVER4
MEDIZINISCHE UNIVERSITAET WIEN4
NATIONAL UNIVERSITY OF IRELAND GALWAY4
RUPRECHT KARLS UNIVERSITAET HEIDELBERG4
TECHNICAL RESEARCH CENTRE OF FINLAND4
THE NETHERLANDS CANCER INSTITUTE / ANTONI VAN LEEUWENHOEK HOSPITAL4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITAET ZUERICH4
UNIVERSITAETSKLINIKUM HEIDELBERG4
UNIVERSITE DE LAUSANNE4
UNIVERSITY OF TURKU4
ARTTIC3
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING3
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC3
EBERHARDKARLSUNIVERSITaeT TueBINGEN3
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN3
FUNDACIO PRIVADA INSTITUT DE RECERCA BIOMEDICA IRB3
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT3
INSERM TRANSFERT3
INSTITUT GUSTAVE ROUSSY3
ISTITUTO SUPERIORE DI SANITA3
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET3
LUND UNIVERSITY3
MOLECULAR MEDICINE3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU3
SERVICIO MADRILENO DE SALUD3
THE HEBREW UNIVERSITY OF JERUSALEM3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II3
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA3
UNIVERSITAET BERN3
UNIVERSITE LIBRE DE BRUXELLES3
UNIVERSITEIT GENT3
UNIVERSITEIT MAASTRICHT3
UNIVERSITEIT VAN AMSTERDAM3
UNIVERSITY MEDICAL CENTER UTRECHT3
UNIVERSITY OF BOLOGNA3
UNIVERSITY OF OSLO3
WAGENINGEN UNIVERSITY3
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACIES SAS2
AGENDIA BV2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
ANAXOMICS BIOTECH S L2
ANDALUSIAN SCHOOL OF PUBLIC HEALTH2
ARISTOTLE UNIVERSITY OF THESSALONIKI2
Constancy:

Total number of partners:1311

Partner loyalty:
Frequent Partner: (> 2 projects): 481
Rare Partner: 830

Frequent / Rare Partner Ratio: 0.58

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES70
RTD HORIZONTAL TOPICS23
INDUSTRY AND TECHNOLOGY6
AGRICULTURE AND MARINE RESOURC4
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2013-05-01Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer SUPERSISTparticipant5.999.9975
2013-05-01Quantitative T cell Immunology QUANTIparticipant4.012.57012
2013-05-01Deciphering the regulatory T cell repertoire: towards biomarkers and biotherapies for autoimmune diseases TRIPODparticipant2.500.0002
2013-02-01PIVOTAL ASSESSMENT OF THE EFFECTS OF BIOACTIVES ON HEALTH AND WELLBEING. FROM HUMAN GENOMA TO FOOD INDUSTRY - PATHWAY PATHWAY-27participant5.999.23125
2013-01-01Early warning signals of ageing in human stem cells and age-related disorders SYSTEMAGEparticipant5.989.9259
2013-01-01Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action EUROFANCOLENparticipant5.380.16911
2012-12-01Systems medicine of chronic inflammatory bowel disease SYSMEDIBDparticipant11.999.99812
2012-12-01Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) NET4CGDparticipant5.999.60711
2012-10-01Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes DIABIL-2participant5.900.0006
2012-08-01Infrastructure for Systems Biology - Europe ISBEparticipant4.745.71823
2012-08-01Global Mapping of Synthetic Genetic Interactions in Drosophila SYNGENEcoordinator2.500.0001
2012-06-01Generating self-antigen diversity in the thymus: from gene expression patterns in single cells to the system level, an integrative approach SELF-TOLERANCEcoordinator2.014.5601
2012-03-01Regulation of Argonaute-2 and miRNA-dependent mRNA decay in response to oxidative stress and DNA damage. MIRNAAGODDRcoordinator167.3901
2012-01-01Target binders TARGETBINDERparticipant3.988.73010
2012-01-01EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations EPIC-CVDparticipant5.987.26627
2012-01-01The DNA damage response pathway in MYCN amplified neuroblastoma DDR-MYCN-NBcoordinator169.3631
2011-12-01Development of a therapeutic HPV vaccine via target epitope identification by mass spectrometry THERAVACcoordinator100.0001
2011-10-01Recruitment and activation of brown adipocytes as preventive and curative therapy for type 2 diabetes DIABATcoordinator5.999.99820
2011-09-01Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe HPV-AHEADparticipant2.999.94610
2011-04-01EU and North African Migrants: Health and Health Systems EUNAMcoordinator1.998.4308
2011-02-01A Social Collaborative Working Space Semantically Interlinking Biomedical Researchers, Knowledge And Data For The Design And Execution Of In-Silico Models And Experiments In Cancer Chemoprevention GRANATUMparticipant2.995.0008
2011-01-01Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria AIPGENEparticipant3.308.1547
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2011-01-01Detection of endpoints and biomarkers of repeated dose toxicity using in vitro systems DETECTIVEparticipant4.337.42515
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15614
2010-09-01Amino acid sensing by TOR TOR-AAcoordinator1.499.2791
2010-06-01Functions and mechanism of active DNA demethylation FMDNADcoordinator2.376.0001
2010-05-01Three modality contrast imaging using multi-functionalized microballoons 3MICRONparticipant5.999.41210
2010-04-01Protein Binders for Characterisation of Human Proteome Function: Generation, Validation, Application AFFINOMICSparticipant11.000.00015
2010-02-01Consortium on Health and Ageing: Network of Cohorts in Europe and the United States CHANCESparticipant11.932.39817
2009-12-01Genetically defined and selectively mast cell-deficient mouse model to unravel the immunological roles of mast cells MAST-CELL-FUNCTIONScoordinator1.880.0001
2009-08-01Selection and improving of fit-for-purpose sampling procedures for specific foods and risks BASELINEparticipant5.154.88520
2009-07-01Function of Non-coding RNAs in Lung Cancer NCRNALUNGCANCERcoordinator100.0001
2009-05-01Collaborative oncological gene-environment study COGSparticipant11.715.50116
2009-05-01Distributed dynamic diversity databases for life 4D4LIFEparticipant3.300.00038
2009-03-01The role of noncoding RNA in sense and antisense or orientation in epigenetic control of rRNA genes RIBOGENEScoordinator831.7561
2009-03-01Advanced affinity tools and technologies for high throughput studies of the human proteome AFFINITYPROTEOMEparticipant2.988.04510
2009-02-01Identification and validation of novel drug targets in Gram-negative bacteria by global search: a trans-system approach ANTIPATHOGNparticipant5.943.96110
2009-01-01Persisting transgenesis PERSISTparticipant11.181.41126
2009-01-01Combinatorial synthesis of peptide arrays with a laser printer PEPLASERparticipant2.988.45012
2008-12-01Natural products and related redox catalysts: basic research and applications in medicine and agriculture RED CATparticipant2.785.65010
2008-11-01INTEGRATION OF THE SYSTEM MODELS OF INSULIN SIGNALLING AND OF MITOCHONDRIAL FUNCTION AND ITS APPLICATION IN THE STUDY OF COMPLEX DISEASES MITINparticipant2.956.4906
2008-11-01Mathematical modelling of beta-catenin and ras signalling in liver and its impact on proliferation, tissue organization and formation of hepatocellular carcinomas CANCERSYSparticipant2.992.0249
2008-09-01Development of carbohydrate array technology to systematically explore the functional role of glycans in healthy and diseased states EUROGLYCOARRAYSparticipant4.046.91517
2008-06-01Personalised and intergrated cardiac care: Patient-specific cardiovascular modelling and simulation for in silico disease understanding and management and for medical device evaluation and optimisation EUHEARTparticipant13.900.00018
2008-05-01Profiling the toxicity of new drugs: a non animal-based approach integrating toxicodynamics and biokinetics PREDICT-IVparticipant11.330.90620
2008-04-01Systems biology of T-cell activation in health and disease SYBILLAparticipant11.100.00020
2008-03-01European consortium for systematic stem cell biology EUROSYSTEMparticipant12.000.00025
2008-01-01The European advanced translational research infrastructure in medicine EATRISparticipant4.200.00020
2007-07-01Coordinating chromosome segregation with cell division: the molecular role of mitotic exit network proteins in the regulation of cytokinesis CYTOKINESIS CONTROLcoordinator1.444.6951

overview shows latest 50 from 102 projects (2000-01-01 - 2013-12-31)

Alias institution names:
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: